Schedule a meeting with us
Wednesday, September 4, 2024 at 5:00PM
Advancing Precision Medicine Globally: From Gene Therapy to HLA CDx Commercialization
Mark J. Roberts
Senior Director - Head of Precision Medicine Science & Strategy, Labcorp
Synopsis
- Lessons from the first cell based CDx FDA approval in gene therapy
- Understand the dynamics of 3-way and 2-way partnerships models between pharma, IVD companies, and Labcorp with real world examples
- Strategic Considerations for Global Commercialization: from early development to trials, regulatory oversight, and post-commercialization support